On Air Now

Listen

Listen Live Now » 98.5 FM Battle Creek, Michigan

Weather

Current Conditions(Battle Creek,MI 49017)

More Weather »
77° Feels Like: 79°
Wind: SW 13 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 60°

Tomorrow

Sunny 81°

Wed Night

Clear 63°

Alerts

Pfizer gets new rebuff from UK cost body for cancer drug

A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. Pfizer Inc. REUTERS/Francois Lenoir
A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. Pfizer Inc. REUTERS/Francois Lenoir

LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was turned down for use on the state health service.

The National Institute for Health and Clinical Excellence (NICE) said on Thursday the new treatment was not a cost-effective use of National Health Service resources.

The decision follows a similar rebuff for Pfizer's lung cancer drug Xalkori on Wednesday.

In both cases, the NICE recommendations are preliminary and subject to further consultation.

(Reporting by Ben Hirschler; Editing by Mark Potter)

Comments